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Physiological and Psychological Effects of Exercise
Interventions in HIV Disease
WESLEY D. DUDGEON, B.A.,1 KENNETH D. PHILLIPS, Ph.D., R.N.,2
CHRISTOPHER M. BOPP, M.S.,1 and GREGORY A. HAND, Ph.D.1
ABSTRACT
The use of both aerobic and resistance exercise has been shown to improve physiologic pa-
rameters such as strength, endurance, time to fatigue, and body composition in the HIV-in-
fected population. Exercise has also been used successfully to treat psychologic conditions
such as depression and anxiety that are common in HIV-infected individuals. However, the
effects of exercise on immune function in these individuals are uncertain because of con-
flicting results found among studies. Additionally, many ventures into this area have been
attempted with poor research design, resulting in inconclusive evidence or poor generaliz-
ability. The focus of this paper is to review the research that has been performed using ex-
ercise as an intervention for HIV-infected persons and to determine what needs to be done




THE COMPLICATIONS resulting from HIV/AIDS radically alter the physiologic and
psychological well-being of HIV-infected indi-
viduals. Treatment with highly active anti-
retroviral therapy (HAART) allows HIV-in-
fected individuals to live longer, healthier, and
more productive lives than was possible at the
beginning of the HIV/AIDS pandemic. How-
ever, these life-extending antiretroviral medica-
tions often cause side effects that may adversely
affect quality of life. Medical researchers are con-
tinually seeking more effective methods to treat
infected individuals; a vaccine that effectively
prevents HIV infection is the ultimate goal.
Health care providers are beginning to pre-
scribe nonpharmacologic complementary and
alternative therapies to prevent and manage
complications associated with HIV/AIDS. An
intriguing, nonpharmacologic treatment for
preventing and managing complications of
HIV infection is moderate intensity exercise
training.1–3 Moderate-intensity exercise train-
ing has been shown not only to be safe, but also
beneficial for increasing lean muscle mass, de-
creasing fat mass, and improving muscular
strength. Additionally, exercise has been shown
1Department of Exercise Science, Arnold School of Public Health, University of South Carolina, Columbia, South
Carolina.
2College of Nursing, University of South Carolina, Columbia, South Carolina.
to improve various mental health problems in
noninfected individuals, thus exercise is being
proposed to improve psychological parameters
in HIV-infected individuals.4,5 The purpose of
this paper is to identify physiologic and psy-
chological alterations that result from HIV/
AIDS and to analyze what is known regarding
the effectiveness of exercise interventions in
preventing and managing these complications.
A literature search was conducted on the
MEDLINE database, with limits set for only
original data, using combinations of the key-
words “exercise,” “HIV,” “AIDS,” and “phys-
ical activity.” This search produced 29 research
studies involving the use of exercise as an in-
tervention for HIV-infected persons. Searching
without limits also produced 12 review articles
on this subject, as well as literature regarding
the functional limitations of HIV-infected indi-
viduals.
Physiologic alterations of HIV infection
HIV-infected persons face many metabolic
conditions that researchers have addressed
with therapeutic exercise. One such condition,
wasting syndrome, is recognized by involun-
tary weight loss of more than 10% baseline
body weight in addition to prolonged fever,
chronic weakness, and chronic diarrhea.6 The
significant loss of tissue present with the wast-
ing syndrome increases the risk of mortality
and secondary infection.6
Lipodystrophy syndrome, a side effect of
HAART, is characterized by fat accumulation
in the abdomen and trunk with fat loss in the
legs, arms, and face.7,8 HAART can increase the
rate of lipid breakdown while decreasing the
rate of lipid synthesis, especially in the pe-
riphery.9 Furthermore, the elevation of circu-
lating cytokine levels, such as tumor necrosis
factor (TNF)-a, that accompany HIV infection
can decrease lipoprotein lipase levels resulting
in a decrease in fat deposition.9
Immune response to chronic fever and in-
fection results in an elevation of circulating cy-
tokines such as interleukin-1 (IL-1) and TNF-a.
Elevated levels of IL-1 and TNF-a can increase
resting energy expenditure, and TNF-a has ad-
ditionally been associated with decreased
lipoprotein lipase activity, depletion of energy
stores, and suppression of food intake.10 In-
creased circulating cytokines further influence
metabolic rates by activating the hypothalamic-
pituitary-adrenal axis (HPAA), which leads to
an increase in glucocorticoid levels. Increased
glucocorticoid levels have a catabolic influence
on skeletal muscle by slowing protein synthe-
sis rate and increasing protein degradation.11
Increased rate of protein turnover and ele-
vated metabolic rate caused by the combined
cytokine and glucocorticoid response can in-
crease resting metabolic rates and lead to ac-
celerated depletion of energy stores. During 
periods of infection, when cytokine and gluco-
corticoid levels rise significantly, resting en-
ergy levels are further elevated and food intake
drops, thus causing accelerated and episodic
weight loss.12–14
HIV-infected individuals also suffer from a
high prevalence of anemia, with reports of up
to 28% prevalence.15 The increase in circulating
cytokines common with HIV-infection can in-
hibit the production of erythropoietin (EPO),
which may partly explain the low EPO levels
reported in HIV-infected individuals.16 Addi-
tionally, certain medications used in the treat-
ment of HIV infection, including zidovudine
and trimethoprim-sulphamethoxazole, have
been linked to development of anemia.17
Psychological alterations of HIV infection
HIV-infected populations have higher inci-
dences of psychiatric disorders than the unin-
fected population.18 The most notable psy-
chological abnormalities include anxiety and
depression. Heckman and colleagues19 found
that 25% of people age 50 or older living with
HIV presented with moderate to severe levels
of depression. This is consistent with the 22%
to 45% prevalence rate of depression in HIV-
infected persons as reported by Penzak and
others,20 who also link depression to altered
course of infection due to impaired immune
function and nonadherence to therapy.
Depressed and anxious HIV-infected indi-
viduals present with decreased natural killer
cell activity, increased viral load, and elevated
CD81 T lymphocytes.21 With the exception of
viral load levels, these are the typical immune
disorders associated with chronic stress.22 Sup-
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pression of immune function can be traced to
hypoactivity of glucocorticoid receptors on im-
mune cells and in limbic regions of the brain.
This in turn may lead to increased secretion of
proinflammatory cytokines and augmented
HPAA activity.23 Thus, management of stress
is significant in treating the HIV-infected pop-
ulation, as increased levels of stress and de-
pression have been associated with more rapid
progression to AIDS.24
Mental health problems are also important
to disease progression because of their nega-
tive effect on drug adherence. It has been found
that HIV-infected individuals suffering from
mental health disorders, regardless of the
severity, have poorer drug adherence.25,26
Specifically, depression has been directly linked
to nonadherence in HIV-infected persons.27–29
Nonadherence to therapy is a major concern
because nonadherence leads to faster disease
progression and to antiviral-resistant strains of
HIV.30–34
Aerobic training
The classification of aerobic as a method of
exercise refers to exercise that requires oxygen
to generate adenosine triphosphate (ATP) for
the functioning of skeletal muscle.35 Aerobic
metabolism of lipids occurs in the muscle mi-
tochondria during b-oxidation, which involves
energy production from plasma free fatty acids
and intramuscular triglycerides. The b-oxida-
tion cycle then feeds acetyl-CoA into the tri-
carboxcyclic acid (TCA) cycle, also located in
the mitochondria, where carbon dioxide (CO2)
and hydrogen (H1) ions are removed. The H1
ions are then passed down the electron trans-
port chain where they are oxidized to produce
ATP. Additionally, glycolysis via the catabo-
lism of blood glucose and/or muscle glycogen
can directly produce energy for the active mus-
cle, as well as producing pyruvate which even-
tually reaches the TCA cycle in the form of
acetyl-CoA.36 Exercise at a level of 3–6 METs (1
MET 5 the amount of energy expended during
1 minute of rest) or 50%–85% maximal oxygen
uptake (VO2max), for 20 to 60 minutes, is gen-
erally prescribed to elicit aerobic condition-
ing.37 Other methods of prescription involve
training in a target heart rate zone, but because
of the occurrence of cardiac neuropathy in HIV-
infected persons,38 this prescription can be un-
reliable.
Current work to date in the prescription of
aerobic exercise for HIV-infected persons has
used stationary cycling and treadmill walking
as modes of conditioning. Typical prescription
has included work at 50%–85% VO2max or
60%–85% maximum heart rate, 3 times per
week for a duration ranging from 10–24 weeks.
Resistance training
Resistance training, or the overloading of
skeletal muscle, serves to increase muscular
strength and muscular endurance. These func-
tional improvements are possible because
skeletal muscle adapts to load by increasing in
size, strengthening connective tissue, and im-
proving bone density.35 Thus, muscle is better
able to perform when a stress is again intro-
duced, and functional performance is en-
hanced. It should be noted, that adaptation of
muscle is specific to the type of training per-
formed. In the reviewed literature progressive
resistance training has also been used as a
means of improving muscular strength and en-
durance. This type of programming aims at en-
suring the appropriate training intensity by
continually increasing resistance as the muscle
adapts to the implemented load.37
Most resistance training is of short duration,
less than 60 seconds, thus anaerobic means of
ATP production are sufficient. Anaerobic en-
ergy production can be carried out by glycoly-
sis, with lactic acid as the byproduct instead of
pyruvate. The creatine phosphate (CP) system,
in which adenosine diphosphate (ADP) and CP
together synthesize ATP, is also a method of
anaerobic ATP production.36
The reviewed work that has used resistance
training as an intervention for HIV infected pop-
ulations shows a common type of program; 3
sessions per week for 8 weeks consisting of 3
sets of 8 repetitions on each exercise. Proper re-
sistance is based on a 1-repetition maximum (1-
RM), preintervention effort on each exercise.
Other programs implement a progressive model
in which the number of repetition and sets re-
mains constant, while the intensity of the exer-
cise is increased at predetermined time points.
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Additional studies have combined aerobic
and resistance exercise into the same inter-
vention. These programs usually last 12–16
weeks, and include 20 minutes of aerobic ac-
tivity followed by 35 to 40 minutes of resis-
tance training. Total workout time has usually
been limited to 1 to 1.5 hours and stretching
has periodically been included.
RESULTS
The immunologic and physiologic and psy-
chologic effects of exercise are summarized in
Tables 1–3.
Physiologic and physiological effects of exercise
Exercise is known to produce many desirable
health benefits in apparently healthy popula-
tions. Studies have shown that regular exercise
reduces the risk of adult onset diabetes,39 hy-
pertension,40 and coronary artery disease.41 Ex-
ercise is also beneficial to those with cancer and
arthritis, conditions that include wasting.42–44
Exercise has been shown to positively alter en-
zymatic activity and increase contractile pro-
tein mass, both effects that aid in combating
wasting.45,46
The literature regarding the effects of exer-
cise on immune function, however, is ambigu-
ous. The primary reason for this lack of cohe-
sion is because of the various methods of data
collection that make comparing results nearly
impossible. The type of exercise prescribed,
whether it is aerobic or resistance, as well as
the intensity of the exercise (light, moderate,
heavy) is also a factor that makes determining
the overall effect of exercise on immune func-
tion difficult. Finally, it is absolutely necessary
to determine the criteria by which immune
function is measured, and whether that mea-
sure has any observable health consequence.
With this in mind, however, much informa-
tion regarding the effects of exercise on im-
mune function have been discovered. After ex-
ercise, there is a biphasic response of the
immune system in which circulating mono-
cytes and lymphocytes decrease below resting
levels,47–49 while a rise in neutrophils is ob-
served, even hours after exercise.50–53 A redis-
tribution of lymphocytes occurs in which helper
T cells are decreased and natural killer (NK)
cell numbers are elevated,49,54 and the ratio of
T-helper to T-suppressor cells can decrease by
half.55,56
Functioning of these immune components
during and after exercise has been addressed.
Exercising within the American College of
Sports Medicine Guidelines (ACSM), 50%–85%
VO2max, will cause a transient decrease in T-
lymphocyte proliferation,50,54,55,57 although no
studies have shown this as being detrimental
to health. Research has also not shown exercise
to alter the functioning of B-lymphocytes or im-
munoglobulin production in any way. What is
clear, however, is that exercise of less than 60
minutes in duration will cause a dose-depen-
dent increase in NK cell function during and
immediately postexercise, but NK cell activity
can then be depressed for up to 180 min-
utes.58–60
Regular exercise can also be beneficial to psy-
chological functioning.61 The use of aerobic ex-
ercise has been shown to reduce the severity of
depressive symptoms and improve mood.62,63
Both aerobic and resistance exercise were also
found to decrease levels of anxiety over an 8-
week period.64
Efficacy of exercise in HIV-infected persons
Calabrese and LaPerriere65 found that exer-
cise is safe and beneficial for HIV-infected per-
sons. To be most beneficial, they recommend
beginning exercise before symptoms present
and also cite the potential of exercise to pro-
vide behavioral benefits. It has even been
shown that exercise after periods of acute in-
fection is safe and beneficial for regaining
weight lost during the symptomatic period.2
While HIV-infected persons are encouraged
to participate in exercise, certain limitations do
exist. Many of these limitations are the result
of loss of lean body mass, decreased muscular
strength, or various metabolic changes that are
side effects of HAART.66 A common deficiency
directly affecting normal daily activities is max-
imal oxygen consumption, VO2max (mL/kg/
min), a measure of functional capacity, which
was found to be “well below average” in ado-
lescents seropositive for the HIV virus com-
pared to age-matched, uninfected controls.67
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High-intensity exercise, which was shown to
decrease the effectiveness of the immune sys-
tem for up to 21-hours in a non-HIV–infected
population in one study,68 was previously
avoided and moderate-intensity exercise was
prescribed. However, Terry et al.69 later found
that high-intensity exercise in an HIV-infected
person may not be detrimental to the immune
system based on data that showed no differ-
ence in CD41 and CD81 cell counts after 12
weeks between groups that exercised at 80%
maximum rate and 60% maximum heart rate.
Immunologic, physiologic, and psychological
effects of aerobic exercise in HIV-infected samples
For these reasons, aerobic training has been
used in many different forms as an interven-
tion for HIV-infected persons. LaPerriere and
colleagues70 used an interval training method
on a cycle ergometer to examine changes in
lymphocyte cell counts in 16 men who began
exercising prior to undergoing HIV screening.
Patients worked at 70%–80% maximum heart
rate for 3 minutes followed by 2-minute ses-
sions at a lower intensity. Findings showed that
45 minutes of training 3 times per week for 5
weeks significantly increased CD41 helper cell
counts (904 vs. 1020 mm3) and the CD81-in-
ducer subset CD45RA1CD41 (no quantification
given) in those who presented as HIV positive.
LaPerriere and coworkers71 also exercised
HIV-infected males, 18–40 years of age, on cy-
cle ergometers 3 times per week for 45 minutes
per session at 70%–80% maximum age-pre-
dicted heart rate for 10 weeks. After comparing
preexercise to postexercise blood lymphocyte
levels, a significant increase was observed in
CD21 (1717 vs. 2183 mm3), CD41 (942 vs. 1280
mm3), CD81 (655 vs. 816 mm3), CD45RA1CD41
(312 vs. 955 mm3), and CD201 (162 vs. 244
mm3) cell counts. These studies by LaPerriere
and associates71 are unique in that they are the
only two to show an actual increase in lym-
phocyte populations. Other studies have
shown that exercise does not decrease lym-
phocyte numbers,5,48,52 as well as showing that
exercise may attenuate the decrease in lym-
phocytes that occurs with normal disease pro-
gression,51 but none have shown an increase in
cell numbers. This observed increase might ac-
tually be the measurement of the mobilization
of cells from the lymphoid tissue, rather than
an actual increase in cell quantity.
Mustafa and colleagues72 also addressed
CD41 cell counts while performing a longitu-
dinal study on 415 homosexual males (156
HIV-infected [CD41 count 555 1 304] and 259
HIV-negative [988 1 380] at the time of enroll-
ment) from 1985–1991 aimed at examining the
association between exercise and HIV disease
progression. Of the 156 HIV-infected men sam-
pled, 68 progressed to AIDS, and 49 died of
AIDS-related complications. Individuals were
asked how many times per week they exer-
cised, with an answer of 3–4 times per week be-
ing considered the minimum for inclusion in
the exercise group and those who exercised less
considered nonexercisers. Using a linear com-
bination of parameter estimates, it was found
that exercise slowed progression to AIDS and
time to death with AIDS. Simple linear regres-
sion using CD41 cell counts as the dependent
variable, showed that CD4 counts increased 1
year, and had a lesser decline in other years
compared to the nonexercising group.
MacArthur and colleagues73 evaluated vari-
ous immunologic and cardiovascular parame-
ters of 25 HIV-infected persons (24 males and
1 female), currently on antiretroviral therapy,
following a 24-week exercise program. Subjects
who exercised at 50%–60% VO2max in four 10-
minute intervals comprised the low-intensity
group, and a high-intensity group worked at
75%–85% VO2max for six 4-minute intervals.
Both groups performed exercise 3 times per
week on a treadmill, stationary bicycle, rower,
or stair-stepper. The 6 individuals who com-
pleted the program, 3 in each group, showed
no significant change in CD41 cell counts at
week 24 (185 vs. 195 cells per microliter), how-
ever, significant improvements were seen in
VO2max (33.2 1 3.3 vs. 41.2 1 4.9 mL/kg per
minute), submaximal heart rate (137 1 8 vs.
124 1 7 beats per minute), and Relative Per-
ceived Effort (RPE) (12.2 1 2.4 vs. 8.5 1 1.4). In-
dividual group data were not analyzed because
of small number of subjects who completed the
intervention resulted in low power to detect
group differences.
Aerobic exercise interventions have also
been designed to evaluate changes in body
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composition and fatigue indices. Smith et al.74
implemented a regimen of 30-minute exercise
sessions 3 times per week for 12 weeks for 60
HIV-infected individuals (52 males and 8 
females). Workloads were set at 60%–80%
VO2max and were increased as needed to keep
the subject’s heart rates within set parameters.
Forty-nine subjects (75% taking antiretrovirals)
completed the program and showed a 1-minute
increase in time to fatigue on a treadmill (a
measure of physical endurance). Subjects in the
exercise group significantly reduced body mass
index (p , 0.04) and decreased body weight by
an average of 1 kg more than the control group
(1.5 kg lost vs. 0.5 kg lost). Included in the loss
of body weight was a significant reduction of
the triceps skinfold (p , 0.01), the peripheral
skinfolds (p , 0.02), and the sum of central
skinfolds (p , 0.02), as well as a reduction of
abdominal girth (p , 0.02). VO2max increased in
the experimental group by 2.6 mL/kg com-
pared to a 1 mL/kg increase in the control
group.
Terry et al.69 divided aerobically exercising
groups into a moderate intensity group who
worked at 60% maximal heart rate (n 5 11) and
high intensity group who exercised at 84%
maximal heart rate (n 5 10). Subjects were seen
3 times per week, and each session lasted ap-
proximately 1 hour with the first 15 minutes
and the last 15 minutes devoted to stretching
and the remaining 30 minutes consisting of
treadmill exercise at the prescribed intensity.
At the completion of the 12-week study, func-
tional capacity, as measured by time to fatigue
on a maximal exercise test, increased in both
groups but more so in the high intensity group
(680 1 81 vs. 750 1 151 seconds for the moder-
ate-intensity group and 651 1 122 vs. 841 1
158 seconds for the high-intensity group),
while no changes in body fat were observed.
Immunologic variables such as CD41 cells (592
vs. 614 vs. 683 mm3), CD81 cells (1030 vs. 1242
vs. 1252 mm3), leukocytes (6344 vs. 6400 vs.
6930 mm3) and lymphocytes (2148 vs. 2627 vs.
2638 mm3) increased at 6 and 12 weeks, re-
spectively, but were not statistically significant.
Depression scores, as obtained with the Mont-
gomery-Asberg scale for depression, remained
unchanged from preintervention to postinter-
vention. These results, however, lack authority
because of low statistical power to detect
changes.
Aerobic exercise has also been linked to im-
provements in the psychological health of HIV-
infected persons. Stringer and others5 evalu-
ated immune indices and quality-of-life scores
before and after a 6-week exercise program.
Twenty-six HIV-infected individuals, 24 of
whom were on antiretroviral therapy, were di-
vided into a control group (n 5 8), a moderate-
intensity exercise group (n 5 9), and a high-in-
tensity exercise group (n 5 9). Aerobic training,
consisting of 6 weeks of 3 sessions per week on
a stationary bicycle, was prescribed with the
moderate-intensity group working approxi-
mately 60 minutes per session and the high-in-
tensity group working less time, approximately
30–40 minutes, to produce equal work. Results
showed no significant change in CD41 count
(moderate, 297 vs. 310 mm3, heavy, 342 vs. 339
mm3) or viral load (moderate, 56,101 vs. 45,698/
mL; heavy: 11,706 vs. 10,326/mL) in any group,
but quality of life scores in the areas of quality
of life, hope, and desire to continue living did
significantly (p , 0.01) improve in both exer-
cise groups.
LaPerriere and colleagues75 recruited 50 ho-
mosexual males unaware of their HIV status to
exercise prior to learning their HIV status. Ex-
ercise was performed on a cycle ergometer for
45 minutes, with 3-minute stages at 80% age
predicted maximum heart rate alternated with
2-minute stages at 60%–79% predicted maxi-
mal heart rate. Based on results from the Pro-
file of Mood States and the State-Trait Anxiety
Inventory, the 10 men in the exercise group
who were diagnosed HIV positive had lower
anxiety (12.8 1 2.0 vs. 12.9 1 2.5) and depres-
sion (14.0 1 3.7 vs. 10.9 1 1.7) scores than did
those HIV-positive men who did not exercise.
Nonexercisers also had a decrease in CD41 cell
number (61 cells/mm3) that was blunted in the
exercise group (increase of 38 cells/mm3).
The effects of aerobic exercise on depression
in HIV-infected individuals were studied by
Neidig and colleagues.76 The 49 subjects who
completed the previously mentioned study by
Smith et al. were also given tests to determine
depression levels using the Center for Epi-
demiological Studies-Depression Scale (CES-
D), the Beck Depression Inventory (BDI), Pro-
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file of Mood States (POMS), and stress was as-
sessed with the Perceived Stress Scale 4 (PSS-
4). Those who completed the exercise inter-
vention showed significant improvement in
CES-D scores (p 5 0.03), the 65-item POMS
(p 5 0.01), and on the depression/rejection
subscale (p 5 0.05).
Physiologic effects of resistance training in 
HIV-infected samples
To assess the ability of the HIV-infected per-
son to adapt to load, Roubenoff and cowork-
ers77 prescribed an 8-week regimen of 3 weekly
sessions consisting of resistance training with 3
sets of 8 repetitions performed at 80% of the
subjects’ 1-RM. The men (n 5 20) and women
(n 5 5), all of whom were taking antiretroviral
therapy, rated the difficulty of each exercise set
on the Borg RPE Scale, and resistance was in-
creased the following session if the RPE was less
than 16. At the conclusion of the 8-week inter-
vention, there was a significant (p , 0.0002) in-
crease in lean body mass (1.75 1 1.94 kg), and
strength (as tested by 1-RM) on the chest press
(31 1 18%), leg press (40 1 23.6%), upper back
(50 1 27%), and quadriceps extension (38 1
31%). There was also a significant (p , 0.05) de-
crease in fat mass (0.92 1 2.22 kg), while over-
all body weight remained the same.
Roubenoff and Wilson1 next compared the
effects of progressive resistance training (PRT)
on physical functioning in wasted (n 5 6) and
nonwasted (n 5 19) HIV-infected populations.
The wasted group was classified by involun-
tary weight loss of greater than 10% baseline
body weight, fewer documented for more than
30 days, chronic weakness, and/or chronic di-
arrhea independent of any conditions other
than HIV-infected that may lead to weight
loss.78 Three subjects with wasting were on an-
tiretroviral therapy and 10 nonwasted subjects
were on antiretroviral therapy. The training
regimen was consistent with the previous
study (3 sessions per week for 8 weeks, with
subjects performing 3 sets of 8 repetitions at
80% 1-RM on the chest press, leg press, leg ex-
tension, and upper back machines). A signifi-
cant increase (p , 0.0001) in strength, assessed
by average 1-RM on four machines, was ob-
served in the wasting group (60% increase) and
the nonwasting group (44% increase). A sig-
nificant, 2.3% increase in lean body mass (LBM)
was observed in the nonwasted group, while
the wasted group exhibited at 5.3% improve-
ment. Wasted subjects also had a significant
(p , 0.05) 6-point improvement on the physi-
cal functioning subscale of the Medical Out-
comes Study (MOS) Short Form 36 (SF-36)
questionnaire.
The effects of resistance exercise, along with
whey protein supplementation, was tested in
30 HIV-infected women by Agin et al.79 Sub-
jects were divided into a protein only group
(n 5 10), an exercise only group (n 5 10), and
a combined therapy group (n 5 10). After a 6-
week control period, 14 weeks of resistance
training was implemented. Results showed no
significant changes in strength or quality of life
(QOL) during the control period. Protein only
patients gained 3.6 kg (p 5 0.001), and 2.5 kg 
of fat (p 5 0.002), with no change in skeletal
muscle mass (0.6 kg; p 5 0.12). The exercise-only
group increased skeletal muscle mass (1.2 kg;
p, 0.001) and decreased fat mass (1.7 kg; p 5
0.02). The combined therapy group had no
change in skeletal muscle (0.6 kg; p 5 0.30).
Strength increased for both exercise groups (40.6
to 95.3%; p, 0.001). The QOL physical activity
score improved for the exercise group (p 5 0.02)
and worsened for protein group (p5 0.01).
Physiologic effects of combined aerobic and
resistance training in HIV-infected samples
The combination of aerobic and resistance
training has been used to treat HIV-infected
persons. Rigsby and colleagues80 subjected 16
patients to a 12-week exercise program con-
sisting of 3 visits per week, and 15 patients at-
tended 1.5 to 2 hour counseling sessions at least
1 time per week during the same 12-week pe-
riod. Subjects in the exercise group performed
20 minutes of aerobic exercise on a stationary
bicycle at 60%–80% maximum heart rate fol-
lowed by 35 minutes of combined strength and
flexibility exercises. Strength training was con-
ducted on a hydraulic isokinetic weight-train-
ing machine and 3 sets were limited to no more
than 30 repetitions total. The results showed
that subjects in the exercise group significantly
improved muscular strength in the chest press
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(189.39 1 25.58 vs. 239.66 1 33.24 n?m newton-
meter) and the leg extension (158.74 1 43.43 vs.
206.28 1 43.06 Newton-meter (n?m) while also
improving cardiorespiratory fitness, as mea-
sured by total time completed during the cycle
test (996.15 1 170.43 vs. 1388.46 1 224.45 sec-
onds), but no improvements were seen in the
counseling group. Measurement of immune
markers showed no significant effect of either
counseling or exercise on total leukocytes, to-
tal lymphocytes, CD41, or CD81 cell counts.
Physiologic effects of exercise and 
anabolic supplementation
It has become common practice to combine
progressive resistance training and anabolic
supplementation when treating AIDS patients.
These treatments are effective in increasing
body weight, but they have been shown to
cause liver toxicity and elevated serum lipid
levels, thus strict monitoring is required.81
Grinspoon and colleagues82 showed that greater
increases in LBM occurred when combining
testosterone and exercise as compared to testos-
terone treatment alone. Subjects with AIDS
wasting were divided into four study groups:
placebo with no exercise (n 5 12), placebo with
exercise (n 5 10), testosterone with no exercise
(n 5 10), testosterone with exercise (n 5 11).
Participants placed in the testosterone groups
received intramuscular testosterone enanthate
injections (200 mg/wk) for the 12-week duration
of the study. The exercise groups trained 3 times
per week, beginning each session with 20 min-
utes of aerobic exercise followed by resistance
training. Resistance training involved 6 exercises
(3 lower body and 3 upper body). Training was
conducted as follows: weeks 1 and 2, 2 sets of 8
repetitions at 60% 1-RM; weeks 3 through 6, 2
sets of 8 repetitions at 70% 1-RM; weeks 7
through 12, 3 sets of 8 repetitions at 80% 1-RM.
LBM significantly increased with training, inde-
pendent of testosterone (2.3 kg), and with testos-
terone an increase of 4.2 kg increase was ob-
served. Isometric strength testing showed no
effect of training or testosterone, but trained sub-
jects did double their training volume.
Bhasin and others83 showed that testosterone
and exercise independently increased LBM and
muscular strength in 16 weeks, although no ad-
ditive effect was observed. Forty-nine HIV-in-
fected males, 18–50 years of age with low
serum testosterone levels and a 5% or greater
weight loss in the previous 6 months completed
the study. Subjects in the exercise groups
trained 3 times per week at 60% of their 1-RM
for 3 sets of 12–15 repetitions for the first 4
weeks. Weeks 5–10 consisted of 4 sets of 4–6
repetitions, with a 90% 1-RM intensity on
heavy days, 80% 1-RM on medium days, and
70% 1-RM on light days. A similar pattern was
followed for the remaining weeks, with upper
body exercise resistance being increased by 7%
and lower body resistance by 12%. Subjects in
the exercise alone group showed a 29%–36% in-
crease in strength, while the testosterone only
group showed a 17%–28% increase, but there
was no additive effect of the two therapies com-
bined. Thigh muscle volume increased by 40
cm3 (p , 0.001) in the testosterone-only group,
by 62 cm3 (p , 0.003) in the exercise-only
group, and volume increased by 44 cm3 (p ,
0.001) in the combined therapy group. Body
weight significantly increased in the testos-
terone only group (p , 0.001), but did not
change in the other two groups receiving ther-
apy. There was no additive effect of the two
therapies on LBM, however, both the testos-
terone-only (p , 0.05) and exercise-only (p ,
0.04) increased significantly.
Sattler and others84 had 14 subjects perform
3 sets of 8 repetitions of resistance exercise at
80% 1-RM, while simultaneously treating them
with a 200-mg injection of nandrolone de-
canoate (anabolic steroid) during week 1, 400
mg for week 2, and 600 mg for the remainder
of the exercise intervention; 14 other subjects
received only the nandrolone deconoate. After
12 weeks, the nandrolone-only group had a sig-
nificant increase in body weight (3.2 1 2.7 kg)
and lean body mass (3.9 1 2.3 kg), but no sig-
nificant change in body fat. The exercise group
also had significant increases in body weight
(4.0 1 2.0 kg) and lean body mass (5.2 1 5.7
kg), which were greater than those observed in
the steroid only group, as well as a significant
decrease in fat mass (1.2 1 1.3 kg). Both groups
also showed significant (p , 0.001) increases in
total thigh, quadriceps, and hamstring muscle
area.
Wagner et al.85 recruited 54 men to partici-
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pate in biweekly treatments of testosterone at
200 mg during weeks 1 and 2, and 400 mg dur-
ing weeks 3–8. Prior to the intervention, and
again at week 12, psychiatrists administered the
Structural Clinical Inventory (used to diagnose
mood disorders), the Hamilton Rating Scale for
Depression (HAM-D), the Brief Symptom In-
ventory (measures distress [BSI-total], anxiety
[BSI-anxiety], and depression [BSI-depression]),
and the Endicott Quality of Life Enjoyment and
Satisfaction Questionnaire (Q-LES-Q). Addi-
tionally, total body weight, lean body mass, and
body fat were measured by bioelectrical im-
pedance at week 0 and week 12. Twenty-nine
men reported engaging in exercise during the
study, with 10 reporting only resistance exer-
cise and 2 reporting only cardiovascular exer-
cise. These men reported exercising an average
of 3.4 days per week, for an average of 87 min-
utes, at an average intensity of 6.1 of 8, with 8
being the most intense. Exercisers showed sig-
nificant (p , 0.000) improvements in each of the
psychological evaluations, while nonexercisers
showed a significant (p , 0.000) improvement
in only the HAM-D. The nonexercisers exhib-
ited no changes in body composition, while the
exercisers had a significant (p , 0.000) im-
provement in lean body mass (61.6 1 7.2 vs.
64.2 1 8.2 kg).
In addition to skeletal muscle adaptations
and changes in fat mass, exercise and testos-
terone used in combination can cause other
metabolic changes. Using the exercise and nan-
drolone deconoate treatment schedule as pre-
viously discussed,75 Sattler et al.86 evaluated
the effects of nandrolone on various risk fac-
tors of cardiovascular disease. Measurement at
week 12 showed a significant increase (p ,
0.03) in low-density lipoprotein (LDL) particle
size in the nandrolone and exercise group, as
well as in total high-density lipoprotein (HDL)
cholesterol in the total population (p , 0.001).
The LDL changes returned to no significance at
week 24, while the total HDL remained signif-
icantly higher (p , 0.01) in the exercise-group
only. Fasting triglycerides were significantly
reduced (p , 0.01) in the total population at
week 12, but this was not sustained through-
out the 24-week study. These results do not al-
low for a definitive statement as to the efficacy
of anabolic therapy in HIV-infected persons in
terms of cardiovascular disease risk factors.
Forty-three HIV-infected men with AIDS
wasting syndrome were recruited by Fairfield
et al.87 to participate in this study. The men were
randomly assigned to the following groups:
placebo with no training (n 5 12), testosterone
(200 mg/wk) with no training (n 5 10), placebo
with training (n 5 10), and testosterone (200
mg/wk) with training (n 5 11). The exercise
protocol consisted of 3 sessions per week for 12
weeks. Each workout consisted of 30 minutes
on a stationary bicycle at 60%–70% the subjects
age predicted maximum heart rate. The resis-
tance exercise for weeks 1 and 2 included 2 sets
of 6–8 repetitions at 60% 1-RM; weeks 3 to 6, 2
sets of 6–8 repetitions at 70%; weeks 7 to 9, 2
sets of 6–8 repetitions at 70% and 1 sets 80%;
and weeks 10 to 12, 3 sets of 6–8 repetitions at
80%. Both testosterone therapy and exercise
were found to increase thigh muscle attenua-
tion, while the combination proved to elicit the
greatest increase (no data).
No research that examines the effects of
lower intensity resistance exercise in HIV-in-
fected populations has been found. The physi-
ologic benefits of resistance training can be at-
tained at intensities below 80% 1-RM, yet
investigators have failed to examine this type
of training. The rationale for using 80% 1-RM
for a resistance training protocol is not de-
scribed by the researchers, but may stem from
recommendations by agencies such as the
ACSM, which state that resistance exercise
above 80% 1-RM is beneficial for rapid gains in
strength.37 The ACSM manual goes on to say
that resistance exercise at 40%–60% 1-RM is
sufficient for the development of strength,
again begging the question as to why this in-
tensity of training has not been tested.37
DISCUSSION
More attention is needed to determine the
type, duration, frequency, and intensity of ex-
ercise needed to elicit physiologic and psycho-
logical changes in the HIV-infected population.
It is evident that no distinct connection has
been made between exercise duration and in-
tensity on CD41 cell counts,5,48–52 leaving more
research to be done regarding exercise and im-
mune indices in the HIV-infected person. These
cell counts can differ by compartment and time
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after exercise, so researchers need to be consis-
tent in retrieving data so true comparisons can
be made. Furthermore, mixed results have been
obtained regarding aerobic exercise prescrip-
tion and psychological evaluations.5,54,55 Stud-
ies of this nature should include a control
group that attends some form of therapy for
the same amount of time the exercise group is
in contact with the research team. Additionally,
with prevalence rates as high as 28%,19 some
consideration should be given to examining the
effects of exercise in the HIV-infected anemic.
Inflammatory and repair mechanisms of the
trained muscle of HIV-infected persons have
yet to be fully documented. Changes in inflam-
matory cytokines (IL-1, IL-6, TNF-a) with HIV-
infection, as well as the presence of chronic 
inflammatory markers caused by chronic infec-
tion, may alter the healing process, and conse-
quently, the adaptive ability of muscle to stress.
Muscle biopsy would provide invaluable in-
sight into these, and many other questions sur-
rounding muscle in an HIV-infected host.
Finally, a major problem with a number of
these studies is low statistical power and ma-
jor threats to internal validity. The problems
can be attributed to differential attrition, with
nonequivalent treatment and control groups.
Validity of the control groups is also compro-
mised by not having the same amount of per-
sonal interaction between treatment and con-
trol groups. Error is also present when using
heart rate as a measure of work rate because
cardiac neuropathy is common to many HIV-
infected persons. All study designs should in-
clude a nutritional assessment to rule diet out
as a confounding variable. Improvement in
study design would allow for better compar-
isons between studies, and may help to explain
discrepancies that exist among them, particu-
larly in terms of impact on CD41 cells.
Study sample characteristics also limit the
generalizability of many of these studies. Many
studies have been done only using males, leav-
ing the effects of exercise on females relatively
unknown.
CONCLUSION
Current research shows that high- and mod-
erate-intensity aerobic training and resistance
training implemented by trained professionals
are both safe and effective in HIV-infected per-
sons. The intervention studies reviewed in this
paper have shown the ability to increase mus-
cular strength and endurance, improve body
composition, and improve mood while not ad-
versely compromising the immune system. For
persons suffering from symptoms, exhaustive
exercise should be avoided, but activity of
moderate intensity is still encouraged. It should
be noted that all HIV-infected individuals and
their trainers should be in constant contact with
the patient’s physician regarding progress and
changes in health and performance levels. Pro-
grams should be designed in accordance with
the ACSM guidelines for exercise testing and
prescription, and careful attention should be
given to avoid overtraining.
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